---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-276881"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T07:40:02.551348+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cerus Q3 revenue up 10% to $46.3M; narrows FY product revenue guidance to $160-162M

## Summary
- Net loss improved to $8.5M ($0.05/sh) from $12.4M ($0.07/sh) in Q3 2021.
- Product gross margin expanded to 55.4% from 51.3% YoY; adjusted EBITDA loss narrowed to $2.7M.
- Cash and investments at $103.8M; net cash used in ops $2.1M vs $6.6M prior year.
- Guidance narrowed to $160-162M product revenue from $160-165M, citing FX headwinds.
- Awarded $9.1M DoD contract for LyoCryo; Health Canada approved 7-day platelet shelf life.

## SEC filing metadata
- accession: 0001193125-22-276881
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312522276881/0001193125-22-276881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312522276881/d306498d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-276881
- JSON: https://secwatch.observer/filing/0001193125-22-276881.json
- Plain text: https://secwatch.observer/filing/0001193125-22-276881.txt

## Key facts
- Earnings Releases
  CERUS CORP reported third quarter ended September 30, 2022 results: revenue $46.3 million, net income $8.5 million, EPS $0.05 per basic and diluted share. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2022
  - Revenue: $46.3 million
  - Net income: $8.5 million
  - EPS: $0.05 per basic and diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Cerus Corporation Announces Third Quarter Financial Results Total Revenue of $46.3 Million Grew 10% YoY in the Third Quarter Product Revenue of $39.6 Million Grew 10% YoY in the Third Quarter despite 6% FX headwind CONCORD, CA, November 3, 2022 - Cerus Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1020214/000119312522276881/0001193125-22-276881-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.